Camp4 Therapeutics (CAMP) EBIT (2023 - 2026)
Camp4 Therapeutics' (CAMP) quarterly EBIT came in at -$13.1 million in Q1 2026, little changed year-on-year from -$13.0 million in Q1 2025, and down 2.31% quarter-over-quarter from -$12.8 million in Q4 2025.
Camp4 Therapeutics (CAMP) EBIT (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has disclosed EBIT across 4 years of filings, most recently posting -$13.1 million for Q1 2026.
- EBIT for Q1 2026 came in at -$13.1 million, changed 0.22% year-over-year; the trailing twelve-month figure through Mar 2026 was -$52.5 million (up 1.47% YoY), and the FY2025 annual result was -$52.6 million, up 1.0% from the prior year.
- EBIT came in at -$13.1 million for Q1 2026 at Camp4 Therapeutics, down from -$12.8 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$12.3 million in Q3 2023 to a low of -$14.0 million in Q4 2024.
- The 4-year median for EBIT is -$13.1 million (2026), against an average of -$13.1 million.
- Across the five-year window, EBIT dropped 9.55% in 2024 and advanced 8.96% in 2025, its largest moves.
- Camp4 Therapeutics' EBIT stood at -$13.5 million in 2023, then fell by 4.14% to -$14.0 million in 2024, then climbed by 8.96% to -$12.8 million in 2025, then decreased by 2.31% to -$13.1 million in 2026.
- The last three EBIT figures came in at -$13.1 million (Q1 2026), -$12.8 million (Q4 2025), and -$13.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -65.83 Mn |
| 10 | Camp4 Therapeutics | 245.02 Mn | 245.02 Mn | - | -13.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.07 Mn |
| Dec 31, 2025 | -12.78 Mn |
| Sep 30, 2025 | -13.65 Mn |
| Jun 30, 2025 | -13.03 Mn |
| Mar 31, 2025 | -13.10 Mn |
| Dec 31, 2024 | -14.03 Mn |
| Sep 30, 2024 | -13.52 Mn |
| Jun 30, 2024 | -12.66 Mn |
| Mar 31, 2024 | -12.88 Mn |
| Dec 31, 2023 | -13.48 Mn |
| Sep 30, 2023 | -12.34 Mn |